Ildong Holdings

000230 · KOSPI · Health Care · SMALL CAP

Provisional Q4 2025 results.

Ildong Holdings filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$106M (−4.1% year on year), operating profit of US$4.97M (+85.7% year on year) and net income of US$10.3M (−82% year on year).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-02-11· RCEPT 20260211801541

US$106MRevenue
−4.1%Revenue vs a year earlier
US$4.97MOperating profit

Converted at 1 USD ≈ ₩1,455.33 (filing-date rate, 2026-02-11 close)

What happened

Ildong Holdings filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$106M (−4.1% year on year), operating profit of US$4.97M (+85.7% year on year) and net income of US$10.3M (−82% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$106M
Revenue vs a year earlier−4.1%
Operating profitUS$4.97M
Net incomeUS$10.3M
PeriodQ4 2025 (consolidated)
Filed2026-02-11, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260211801541 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-11 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.